Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2004
03/17/2004EP1397364A1 Novel pyrrole derivatives as pharmaceutical agents
03/17/2004EP1397363A1 5-ethyl-imidazotriazinones
03/17/2004EP1397362A2 Triazolopyrimidines having a fungicidal effect
03/17/2004EP1397360A1 Azaindoles
03/17/2004EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
03/17/2004EP1397137A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
03/17/2004EP1289994B1 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY 1,2,4]TRIAZOLO 1,5-c]PYRIMIDINE
03/17/2004EP1244674B1 Microbicidal effect of porphyrines in darkness
03/17/2004EP1144413B1 2,5-diazabicyclo 2.2.1]heptane derivatives, their preparation and therapeutic uses
03/17/2004EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
03/17/2004EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
03/17/2004EP1137739B1 Catalytic cracking process using an mcm-68 catalyst
03/17/2004EP1135391B1 Novel triazolo(4,5-d)pyrimidine compounds
03/17/2004EP1030686B1 Lyophilizate of lipid complex of water insoluble porphyrins
03/17/2004EP0966769B1 Novel electrode materials derived from polyquinoid ionic compounds and their uses in electrochemical generators
03/17/2004EP0891362B1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/17/2004EP0891332B1 6-phenylpyridyl-2-amine derivatives
03/17/2004EP0731807B1 N-2 substituted purines
03/17/2004CN1483034A Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/17/2004CN1142165C Preparation of partially synthesized deuteroporphyrin derivative and its freezing dried injection
03/17/2004CN1142164C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substituent causing optical activity and process for preparing thereof
03/16/2004US6706889 Dinitropyrazolopyrazole-amine salts useful in gun propellants
03/16/2004US6706720 Heterocyclic dihydropyrimidine compounds
03/16/2004US6706714 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivatives
03/16/2004US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
03/16/2004CA2096460C Dual action inhibitors
03/16/2004CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
03/11/2004WO2004020547A1 Reactive dendrimers
03/11/2004WO2004020529A1 Metaloxyphthalocyanine compounds
03/11/2004WO2004020442A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
03/11/2004WO2004020417A1 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors
03/11/2004WO2004019943A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/11/2004WO2004005279A3 Substituted anthranilic amide derivatives and methods of use
03/11/2004WO2003096782A3 Process for preparing maytansinol
03/11/2004WO2003078420A3 Process for making chiral 1,4-disubstituted piperazines
03/11/2004WO2003063864A3 Heterocyclic compounds which are active as inhibitors of beta lactamases
03/11/2004WO2003009809A3 Cancer treatment with gö6976 and its related compounds
03/11/2004WO2003000695A8 Pyrrolopyrimidines as protein kinase inhibitors
03/11/2004WO2002076404A3 Fatty alcohol drug conjugates
03/11/2004US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
03/11/2004US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2004US20040049030 Such as naphthalenes, anthracenes, phenanthrenes, tetracenes, perylenes, terrylenes, quaterrylenes, pentarylenes, hexarylenes, anthraquinones, indanthrones, and N-substituted naphthalene-1,8-dicarboxylic monoimides
03/11/2004US20040048915 Methods and compounds for treating proliferative diseases
03/11/2004US20040048912 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
03/11/2004US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc.
03/11/2004US20040048882 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted
03/11/2004US20040048879 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
03/11/2004US20040048868 Benzimidazoles
03/11/2004US20040048853 Compounds, compositions, and methods
03/11/2004US20040048849 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
03/11/2004US20040048847 Increasing the sugar-transporting capacity; preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis
03/11/2004US20040048843 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion
03/11/2004US20040048797 Regulation of TNF-alpha
03/11/2004US20040048346 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
03/11/2004DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders
03/11/2004DE10238723A1 Phenyl-substituierte Pyrazolyprimidine Phenyl-substituted Pyrazolyprimidine
03/11/2004CA2495248A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/10/2004EP1396490A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
03/10/2004EP1396487A1 Phenylpyridine carbonyl piperazine derivative
03/10/2004EP1396486A1 Bis-paraphenylendiamine derivatives comprising pyrrolidine groups and their use for the colouration of keratinic fibres
03/10/2004EP1395606A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
03/10/2004EP1395595A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
03/10/2004EP1395594A1 New benzylaminopyrimidines
03/10/2004EP1395593A1 Novel pyrazolopyrimidinethione derivatives. preparation methods thereof and their use as therapeutics for erectile dysfunction
03/10/2004EP1395592A1 Novel pyridylmethylaminopyrimidines
03/10/2004EP1395591A1 Corticotropin releasing factor antagonists
03/10/2004EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists
03/10/2004EP1395589A1 Imidazo-triazine derivatives as pde 5 inhibitors
03/10/2004EP1395585A1 Antibacterial agents
03/10/2004EP1395584A1 Uronium and immonium salts for peptide coupling
03/10/2004EP1395259A2 Urazole compounds useful as anti-inflammatory agents
03/10/2004EP1395117A1 Use of triazolopyrimidine derivatives as microbicides in the protection of materials
03/10/2004EP1177196B1 Heteroaryl diazabicycloalkanes, their preparation and use
03/10/2004EP1140942B1 Prenyl transferase inhibitors
03/10/2004EP0994875B1 3-pyridyl-1-azabicycloalkane derivatives for prevention and treatment of cns disorders
03/10/2004CN1481387A Condensed purine derivatives as A1 adenosine receptor antagonists
03/10/2004CN1481386A Method for producing sulfonamide-substituted imidazotriazinones
03/10/2004CN1481369A Substituted phenyluracils compound
03/10/2004CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives
03/10/2004CN1141295C Indoline derivatives as progesterohe antagonists
03/09/2004US6703500 Method of preparing bicyclic intermediates from piperazic acid or an ester thereof useful in the manufacture of caspase inhibitors
03/09/2004US6703404 Nitric oxide synthase inhibitors
03/09/2004US6703393 Treatment of a variety of central nervous system (cns) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or alzheimer's dementia,
03/09/2004US6703391 Quinoxalinedione derivatives, their preparation and use
03/09/2004US6703387 Inhibitors of HPV E1 helicase enzyme
03/04/2004WO2004019283A2 Methods for regulating transcription by targeting quadruplex dna
03/04/2004WO2004018495A1 Process for producing indolopyrrolocarbazole derivative
03/04/2004WO2004018477A2 Liquid crystal display and colour filter with improved transparency for green light
03/04/2004WO2004018476A1 Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
03/04/2004WO2004018475A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
03/04/2004WO2004018474A1 Phenyl-substituted pyrazolopyrimidines
03/04/2004WO2004018473A2 Azapurine derivatives
03/04/2004WO2004018472A2 Pyrimido compounds having antiproliferative activity
03/04/2004WO2004018459A1 Pyrazole derivatives as gnrh inhibitors
03/04/2004WO2004018455A1 Pyrrole based inhibitors of glycogen synthase kinase 3
03/04/2004WO2004018438A2 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives
03/04/2004WO2004018428A1 Antibacterial benzoic acid derivatives
03/04/2004WO2004018420A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
03/04/2004WO2004018058A2 Compounds, compositions, and methods